MedPath

Assessment of eye inflammation after intravitreal injection injectio

Not Applicable
Recruiting
Conditions
Iridocyclitis
H20.0
Registration Number
RBR-95ddhp
Lead Sponsor
niversidade Federal de São Paulo
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
Not specified
Inclusion Criteria

Patients with indication for intravitreal anti-VEGF injection followed by vitrectomy to treat complications of diabetic retinopathy.

Exclusion Criteria

Glaucoma; previous or current history of uveitis; previous vitreoretinal surgery; patients who have contraindications to the use of anti-VEGF.

Study & Design

Study Type
Intervention
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Increased eye inflammation in the agitated group in the laboratory, by measuring cytokine levels in aqueous humor using the Cytometric Bead Assay method;Increased eye inflammation in the agitated group in the laboratory, by measuring cytokine levels in aqueous humor using the Cytometric Bead Assay method
Secondary Outcome Measures
NameTimeMethod
ão são esperados desfechos secundários
© Copyright 2025. All Rights Reserved by MedPath